MRZK Pharma: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MRZK Pharma
Largest movements
- Receivables within one year +€42,519
up €42,519 (+7.7%), from €555,742 to €598,261
of which Other amounts receivable: +€24,796
- Reserves +€35,837
up €35,837 (+7.1%), from €501,847 to €537,684
of which Distributable reserves: +€35,837
- Gross operating margin +€40,946
up €40,946 (+24.0%), from €170,476 to €211,421
- Staff costs +€33,470
up €33,470 (+25.9%), from €129,001 to €162,471
- Financial income -€4,539
down €4,539 (-33.5%), from €13,567 to €9,028
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €684,544 | €721,142 | +€36,598 | +5.3% |
| Fixed assets | 21/28 | €17,057 | €13,543 | -€3,514 | -20.6% |
| Tangible fixed assets | 22/27 | €15,520 | €12,006 | -€3,514 | -22.6% |
| Plant, machinery and equipment | 23 | €5,134 | €3,317 | -€1,817 | -35.4% |
| Furniture and vehicles | 24 | €8,248 | €7,665 | -€583 | -7.1% |
| Other tangible fixed assets | 26 | €2,138 | €1,024 | -€1,113 | -52.1% |
| Financial fixed assets | 28 | €1,537 | €1,537 | = | 0.0% |
| Current assets | 29/58 | €667,487 | €707,599 | +€40,112 | +6.0% |
| Stocks and contracts in progress | 3 | €87,678 | €87,781 | +€103 | +0.1% |
| Stocks | 30/36 | €87,678 | €87,781 | +€103 | +0.1% |
| Amounts receivable within one year | 40/41 | €555,742 | €598,261 | +€42,519 | +7.7% |
| Trade receivables | 40 | €221,021 | €238,743 | +€17,722 | +8.0% |
| Other amounts receivable | 41 | €334,722 | €359,518 | +€24,796 | +7.4% |
| Cash at bank and in hand | 54/58 | €24,067 | €21,557 | -€2,510 | -10.4% |
| Total equity and liabilities | 10/49 | €684,544 | €721,142 | +€36,598 | +5.3% |
| Equity | 10/15 | €520,447 | €556,284 | +€35,837 | +6.9% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €501,847 | €537,684 | +€35,837 | +7.1% |
| Tax-exempt reserves | 132 | €8,000 | €8,000 | = | 0.0% |
| Distributable reserves | 133 | €493,847 | €529,684 | +€35,837 | +7.3% |
| Amounts payable | 17/49 | €164,097 | €164,857 | +€761 | +0.5% |
| Amounts payable within one year | 42/48 | €164,097 | €164,857 | +€761 | +0.5% |
| Trade debts | 44 | €149,267 | €145,631 | -€3,637 | -2.4% |
| Suppliers | 440/4 | €149,267 | €145,631 | -€3,637 | -2.4% |
| Taxes, remuneration and social security | 45 | €14,829 | €19,227 | +€4,397 | +29.7% |
| Remuneration and social security | 454/9 | €14,829 | €19,227 | +€4,397 | +29.7% |
| Remuneration, social security and pensions | 62 | €129,001 | €162,471 | +€33,470 | +25.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €5,417 | €6,432 | +€1,015 | +18.7% |
| Other operating charges | 640/8 | €2,087 | €1,475 | -€613 | -29.4% |
| Gross operating margin | 9900 | €170,476 | €211,421 | +€40,946 | +24.0% |
| Operating profit (loss) | 9901 | €33,970 | €41,044 | +€7,074 | +20.8% |
| Financial income | 75/76B | €13,567 | €9,028 | -€4,539 | -33.5% |
| Recurring financial income | 75 | €13,567 | €9,028 | -€4,539 | -33.5% |
| Financial charges | 65/66B | €474 | €650 | +€176 | +37.0% |
| Recurring financial charges | 65 | €474 | €650 | +€176 | +37.0% |
| Profit (loss) for the period before taxes | 9903 | €47,063 | €49,422 | +€2,359 | +5.0% |
| Income taxes | 67/77 | €12,908 | €13,585 | +€677 | +5.2% |
| Profit (loss) for the period | 9904 | €34,155 | €35,837 | +€1,683 | +4.9% |
| Profit (loss) for the period to be appropriated | 9905 | €34,155 | €35,837 | +€1,683 | +4.9% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.